. Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics. Alzheimers Dement (Amst). 2016;2:86-94. Epub 2016 Jan 19 PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
YKL-40
(CSF)
AD
(20)
277.625 ± 952.891
ng/mL §
ELISA;
Other/Not Specified;
Quidel Corporation
McKhann et al., 2011; McKhann et al., 1984
YKL-40
(CSF)
CTRL-
CNC
(23)
211.655 ± 855.539
ng/mL §
ELISA;
Other/Not Specified;
Quidel Corporation
YKL-40
(CSF)
DLB
(20)
236.845 ± 752.277
ng/mL §
ELISA;
Other/Not Specified;
Quidel Corporation
McKeith et al., 2005
YKL-40
(CSF)
FTD-
FTLD-TDP43
(20)
323.039 ± 1176.06
ng/mL §
ELISA;
Other/Not Specified;
Quidel Corporation
Rascovsky et al., 2011
YKL-40
(CSF)
FTD-
FTLD-Tau
(10)
378.514 ± 901.3
ng/mL §
ELISA;
Other/Not Specified;
Quidel Corporation
Rascovsky et al., 2011
YKL-40
(CSF)
VaD
(18)
263.289 ± 962.299
ng/mL §
ELISA;
Other/Not Specified;
Quidel Corporation
Román et al., 1993

§ Data supplied to Alzforum by author

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.